
Michael Pollan and Xand Van Tulleken on the Science of Psychedelics
Intelligence Squared
Challenges and Risks in Psychedelic Drug Research
The pharmaceutical industry is primarily interested in buying out small companies that find ways to profit from psychedelic drugs. They don't invest in researching psychiatric drugs. There are concerns about negative media stories affecting the progress of psychedelic drug research, such as cases of suicide or sexual abuse. Additionally, there's a fear of a political backlash and the negative association of suicide with psychedelic drugs, even though similar risks exist with traditional SSRIs.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.